Generation Bio GBIO Stock
2.75 USD
{{ price }}
-2.135230%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
United States
Exchange
NasdaqGS
Market Cap
245.97M USD
LOW - HIGH [24H]
3.6
-
4.09 USD
VOLUME [24H]
145.88K USD
{{ volume }}
P/E Ratio
0
Earnings per share
-1.96 USD
Generation Bio Price Chart
Generation Bio GBIO Financial and Trading Overview
| Generation Bio stock price | 2.75 USD |
| Previous Close | 4.94 USD |
| Open | 4.9 USD |
| Bid | 0 USD x 1100 |
| Ask | 0 USD x 800 |
| Day's Range | 4.74 - 5.04 USD |
| 52 Week Range | 3.15 - 8.72 USD |
| Volume | 118.83K USD |
| Avg. Volume | 443.78K USD |
| Market Cap | 325.75M USD |
| Beta (5Y Monthly) | 1.986496 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.96 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 12.33 USD |
GBIO Valuation Measures
| Enterprise Value | 118.15M USD |
| Trailing P/E | N/A |
| Forward P/E | -2.4924624 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 1.1645927 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -0.906 |
Trading Information
Generation Bio Stock Price History
| Beta (5Y Monthly) | 1.986496 |
| 52-Week Change | -18.55% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 8.72 USD |
| 52 Week Low | 3.15 USD |
| 50-Day Moving Average | 4.48 USD |
| 200-Day Moving Average | 4.92 USD |
GBIO Share Statistics
| Avg. Volume (3 month) | 443.78K USD |
| Avg. Daily Volume (10-Days) | 166.29K USD |
| Shares Outstanding | 65.67M |
| Float | 48.48M |
| Short Ratio | 17.24 |
| % Held by Insiders | 14.71% |
| % Held by Institutions | 96.51% |
| Shares Short | 2.25M |
| Short % of Float | 5.88% |
| Short % of Shares Outstanding | 3.42% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -19.36% |
| Return on Equity (ttm) | -42.31% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -130341000 USD |
| Net Income Avi to Common (ttm) | -133734000 USD |
| Diluted EPS (ttm) | -2.04 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 288.65M USD |
| Total Cash Per Share (mrq) | 4.4 USD |
| Total Debt (mrq) | 82.36M USD |
| Total Debt/Equity (mrq) | 29.51 USD |
| Current Ratio (mrq) | 15.162 |
| Book Value Per Share (mrq) | 4.259 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -94690000 USD |
| Levered Free Cash Flow (ttm) | -108750496 USD |
Profile of Generation Bio
| Country | United States |
| State | MA |
| City | Cambridge |
| Address | 301 Binney Street |
| ZIP | 02142 |
| Phone | 617 655 7500 |
| Website | https://generationbio.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 150 |
Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.
Q&A For Generation Bio Stock
What is a current GBIO stock price?
Generation Bio GBIO stock price today per share is 2.75 USD.
How to purchase Generation Bio stock?
You can buy GBIO shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Generation Bio?
The stock symbol or ticker of Generation Bio is GBIO.
Which industry does the Generation Bio company belong to?
The Generation Bio industry is Biotechnology.
How many shares does Generation Bio have in circulation?
The max supply of Generation Bio shares is 89.44M.
What is Generation Bio Price to Earnings Ratio (PE Ratio)?
Generation Bio PE Ratio is now.
What was Generation Bio earnings per share over the trailing 12 months (TTM)?
Generation Bio EPS is -1.96 USD over the trailing 12 months.
Which sector does the Generation Bio company belong to?
The Generation Bio sector is Healthcare.
Generation Bio GBIO included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Global Select Market Com NQGS | 7876.03 USD — |
-1.61
|
— — | 7852.08 USD — | 7955.84 USD — | — - | — — |
| NASDAQ Biotechnology NBI | 4195.13 USD — |
-2.14
|
— — | 4174.1 USD — | 4266.29 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
| Stlmt ID NASDAQ Biotechnology NBX | 4604.4 USD — |
-2.98
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
- {{ link.label }} {{link}}